Next-generation sequencing of patients with congenital anosmia

We performed whole exome or genome sequencing in eight multiply affected families with ostensibly isolated congenital anosmia. Hypothesis-free analyses based on the assumption of fully penetrant recessive/dominant/X-linked models obtained no strong single candidate variant in any of these families. In total, these eight families showed 548 rare segregating variants that were predicted to be damaging, in 510 genes. Three Kallmann syndrome genes (FGFR1, SEMA3A, and CHD7) were identified. We performed permutation-based analysis to test for overall enrichment of these 510 genes carrying these 548 variants with genes mutated in Kallmann syndrome and with a control set of genes mutated in hypogonadotrophic hypogonadism without anosmia. The variants were found to be enriched for Kallmann syndrome genes (3 observed vs. 0.398 expected, p = 0.007), but not for the second set of genes. Among these three variants, two have been already reported in genes related to syndromic anosmia (FGFR1 (p.(R250W)), CHD7 (p.(L2806V))) and one was novel (SEMA3A (p.(T717I))). To replicate these findings, we performed targeted sequencing of 16 genes involved in Kallmann syndrome and hypogonadotrophic hypogonadism in 29 additional families, mostly singletons. This yielded an additional 6 variants in 5 Kallmann syndrome genes (PROKR2, SEMA3A, CHD7, PROK2, ANOS1), two of them already reported to cause Kallmann syndrome. In all, our study suggests involvement of 6 syndromic Kallmann genes in isolated anosmia. Further, we report a yet unreported appearance of di-genic inheritance in a family with congenital isolated anosmia. These results are consistent with a complex molecular basis of congenital anosmia.

[1]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[2]  K. Huoponen,et al.  Molecular analysis of the CHD7 gene in CHARGE syndrome: identification of 22 novel mutations and evidence for a low contribution of large CHD7 deletions , 2007, Genetics in Medicine.

[3]  Jean-Pierre Fryns,et al.  Three cases of two unrelated families with a microduplication 22q11.2: developmental skull defects and phenotype variability , 2011 .

[4]  S. Bale,et al.  Mutations in the CHD7 gene: the experience of a commercial laboratory. , 2010, Genetic testing and molecular biomarkers.

[5]  N. Tommerup,et al.  Isolated and syndromic forms of congenital anosmia , 2012, Clinical Genetics.

[6]  Shaun K Olsen,et al.  Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. , 2007, The Journal of clinical investigation.

[7]  Philippe Rombaux,et al.  Imaging the olfactory tract (cranial nerve #1). , 2010, European journal of radiology.

[8]  O. Laccourreye,et al.  PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency. , 2012, European journal of endocrinology.

[9]  Scott T. Wong,et al.  Disruption of the Type III Adenylyl Cyclase Gene Leads to Peripheral and Behavioral Anosmia in Transgenic Mice , 2000, Neuron.

[10]  T. Hummel,et al.  The first mutation in CNGA2 in two brothers with anosmia , 2015, Clinical genetics.

[11]  K. Shianna,et al.  Using ERDS to infer copy-number variants in high-coverage genomes. , 2012, American journal of human genetics.

[12]  F. Zufall,et al.  Loss-of-function mutations in sodium channel Nav1.7 cause anosmia , 2011, Nature.

[13]  Paul M. Jenkins,et al.  Hypomorphic CEP290/NPHP6 mutations result in anosmia caused by the selective loss of G proteins in cilia of olfactory sensory neurons , 2007, Proceedings of the National Academy of Sciences.

[14]  K. Devriendt,et al.  Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis , 2007, Human mutation.

[15]  D. Lancet,et al.  A role for TENM1 mutations in congenital general anosmia , 2016, Clinical genetics.

[16]  J. Ngai,et al.  General Anosmia Caused by a Targeted Disruption of the Mouse Olfactory Cyclic Nucleotide–Gated Cation Channel , 1996, Neuron.

[17]  E. Boerwinkle,et al.  dbNSFP v2.0: A Database of Human Non‐synonymous SNVs and Their Functional Predictions and Annotations , 2013, Human mutation.

[18]  L. Holmes,et al.  The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. , 1996, The Journal of clinical endocrinology and metabolism.

[19]  V. Willour,et al.  Exome Sequencing of Familial Bipolar Disorder. , 2016, JAMA psychiatry.

[20]  Bethan E. Hoskins,et al.  Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse , 2004, Nature Genetics.

[21]  Dalong Zhu,et al.  Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients , 2015, Experimental biology and medicine.

[22]  Bradley P. Coe,et al.  Copy number variation detection and genotyping from exome sequence data , 2012, Genome research.

[23]  M. Maghnie,et al.  Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment , 2015, Nature Reviews Endocrinology.

[24]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[25]  L. Hoefsloot,et al.  CHD7 mutations in patients initially diagnosed with Kallmann syndrome – the clinical overlap with CHARGE syndrome , 2009, Clinical genetics.

[26]  M. de Castro,et al.  Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia. , 2006, The Journal of clinical endocrinology and metabolism.

[27]  Josyf Mychaleckyj,et al.  Robust relationship inference in genome-wide association studies , 2010, Bioinform..

[28]  J. Hardelin,et al.  The Complex Genetics of Kallmann Syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. , 2008, Sexual Development.

[29]  Y. Gilad,et al.  General Olfactory Sensitivity Database (GOSdb): Candidate Genes and their Genomic Variations , 2013, Human mutation.

[30]  E. Fliers,et al.  Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes , 2006, Molecular and Cellular Endocrinology.

[31]  R. Axel,et al.  Mice Deficient in Golf Are Anosmic , 1998, Neuron.

[32]  Jacques Young,et al.  SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development. , 2012, Human reproduction.

[33]  H. Petit,et al.  Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation , 1987, Journal of the Neurological Sciences.

[34]  Hyung-Goo Kim,et al.  The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. , 2011, Fertility and sterility.

[35]  R. Quinton,et al.  Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory , 2011, Trends in Endocrinology & Metabolism.

[36]  F. Speleman,et al.  Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome , 2003, Nature Genetics.

[37]  P. Rombaux,et al.  How to measure olfactory bulb volume and olfactory sulcus depth? , 2009, B-ENT.

[38]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[39]  N. Niikawa,et al.  Isolated congenital anosmia locus maps to 18p11.23-q12.2 , 2004, Journal of Medical Genetics.

[40]  J. Hardelin,et al.  The Complex Genetics of Kallmann Syndrome : KAL 1 , FGFR 1 , FGF 8 , PROKR 2 , PROK , 2008 .

[41]  C. Petit,et al.  Kallmann Syndrome: Mutations in the Genes Encoding Prokineticin-2 and Prokineticin Receptor-2 , 2006, PLoS genetics.

[42]  D. Goldstein,et al.  Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes , 2013, PLoS genetics.

[43]  R. Axel,et al.  Mice deficient in G(olf) are anosmic. , 1998, Neuron.

[44]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[45]  Soo-Hyun Kim.  Congenital Hypogonadotropic Hypogonadism and Kallmann Syndrome: Past, Present, and Future , 2015, Endocrinology and metabolism.

[46]  J. Hardelin,et al.  The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients. , 2014, The Journal of clinical endocrinology and metabolism.

[47]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[48]  J. Hardelin,et al.  Kallmann syndrome , 2009, European Journal of Human Genetics.

[49]  L. Layman.  Clinical genetic testing for Kallmann syndrome. , 2013, The Journal of clinical endocrinology and metabolism.

[50]  D. Lancet,et al.  Mutations in olfactory signal transduction genes are not a major cause of human congenital general anosmia. , 2007, Chemical senses.

[51]  Tsviya Olender,et al.  VarElect: the phenotype-based variation prioritizer of the GeneCards Suite , 2016, BMC Genomics.

[52]  J. C. Davis,et al.  Identical twins discordant for Kallmann's syndrome. , 1990, Journal of medical genetics.

[53]  J. Hardelin,et al.  SEMA3A, a Gene Involved in Axonal Pathfinding, Is Mutated in Patients with Kallmann Syndrome , 2012, PLoS genetics.